Atea Pharmaceuticals Inc. (AVIR)

AI Score

Unlock

2.97

-0.03 (-1.00%)

At close: Apr 17, 2025, 3:59 PM

2.98

0.34%

After-hours: Apr 17, 2025, 04:57 PM EDT

Atea Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	192.18M	224.99M	285.38M	351.37M	207.82M	175.01M	114.62M	48.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	208K	312K	416K	416K	416K	416K	15.46M	15.4M	15.32M	15.22M	43.09M	82.85M	109.4M	123.24M	93.82M	61.77M	38.02M	34.35M	20.75M	12.99M	10.17M	n/a	n/a	n/a
Gross Profit	-208K	-312K	-416K	-416K	-416K	-416K	-15.46M	-15.4M	-15.32M	176.96M	181.9M	202.53M	241.97M	84.58M	81.19M	52.84M	10.61M	-34.35M	-20.75M	-12.99M	-10.17M	n/a	n/a	n/a
Operating Income	-192.95M	-200.5M	-204.08M	-192.4M	-164.16M	-157.49M	-132.98M	-130.04M	-130.65M	30.43M	24.56M	65.55M	138.38M	37.84M	42.36M	23.67M	-11.03M	-36.43M	-22.57M	-16.28M	-14.61M	-9.86M	-6.09M	-2.37M
Interest Income	25.49M	27.54M	29.13M	29.79M	29.22M	27.06M	23.57M	17.35M	11.15M	5.61M	1.28M	254K	214K	172K	126K	84K	83K	168K	298K	452K	574K	480K	343K	179K
Pretax Income	-167.46M	-172.96M	-174.95M	-162.61M	-134.94M	-130.43M	-109.41M	-112.69M	-119.5M	36.04M	25.85M	65.8M	138.59M	38.01M	42.49M	23.75M	-10.95M	-36.26M	-22.27M	-15.83M	-14.03M	-9.38M	-5.75M	-2.19M
Net Income	-168.38M	-174.01M	-176M	-163.66M	-135.96M	-131.22M	-106.15M	-109.3M	-115.81M	35.75M	15.62M	48.5M	121.19M	24.71M	35.29M	23.75M	-10.95M	-36.26M	-22.27M	-15.83M	-14.03M	-9.38M	-5.75M	-2.19M
Selling & General & Admin	48.64M	46.71M	48.27M	49.33M	49.81M	50.75M	49.52M	48.79M	48.71M	49.54M	50.11M	49.57M	45.79M	46.74M	38.83M	29.18M	21.64M	8.76M	6.09M	4.73M	4.44M	3.18M	1.82M	928K
Research & Development	144.1M	153.47M	155.5M	142.86M	114.24M	106.74M	83.46M	81.26M	81.94M	112.21M	150.32M	170.27M	167.2M	123.24M	93.82M	61.77M	38.02M	27.67M	16.48M	11.55M	10.17M	6.68M	4.27M	1.44M
Other Expenses	-23.21M	-23.21M	-23.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	192.74M	200.19M	203.77M	192.19M	164.06M	157.49M	132.98M	130.04M	130.65M	161.75M	200.43M	219.84M	212.99M	169.98M	132.65M	90.95M	59.66M	36.43M	22.57M	16.28M	14.61M	9.86M	6.09M	2.37M
Interest Expense	n/a	n/a	n/a	n/a	n/a	5.59M	5.59M	6.67M	6.77M	1.18M	1.18M	98K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-208K	-312K	-312K	-208K	-104K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	192.95M	200.5M	204.08M	192.4M	164.16M	157.49M	132.98M	130.04M	130.65M	161.75M	200.43M	219.84M	212.99M	169.98M	132.65M	90.95M	59.66M	36.43M	22.57M	16.28M	14.61M	9.86M	6.09M	2.37M
Income Tax Expense	925K	1.05M	1.04M	1.05M	1.02M	792K	-3.26M	-3.39M	-3.69M	289K	10.22M	17.3M	17.4M	13.3M	7.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	84.46M	84.42M	84.25M	83.92M	83.44M	83.4M	83.4M	83.33M	83.29M	83.26M	83.26M	83.18M	83.1M	82.82M	82.74M	82.58M	82.58M	79.24M	47.29M	47.29M	47.29M	47.29M	10.09M	10.09M
Shares Outstanding (Diluted)	84.46M	84.42M	84.25M	83.92M	83.44M	83.4M	83.4M	83.33M	83.29M	83.26M	83.26M	83.18M	87.09M	82.82M	88.09M	89.1M	89.1M	79.24M	47.29M	47.29M	47.29M	47.29M	10.09M	10.09M
EPS (Basic)	-2	-2.07	-2.1	-1.96	-1.64	-1.58	-1.28	-1.32	-1.39	0.43	0.19	0.59	1.46	0.30	0.42	0.19	-0.26	-0.61	-0.47	-0.61	-0.75	-0.65	-0.57	-0.22
EPS (Diluted)	-2	-2.07	-2.1	-1.96	-1.64	-1.58	-1.28	-1.32	-1.39	0.36	0.12	0.52	1.36	0.25	0.37	0.14	-0.28	-0.61	-0.47	-0.61	-0.75	-0.65	-0.57	-0.22
EBITDA	-192.74M	-192.53M	-196.11M	-184.43M	-156.2M	-151.69M	-127.19M	-124.25M	-124.95M	30.44M	24.59M	65.58M	138.41M	37.87M	42.39M	23.69M	-11.01M	-36.41M	-22.55M	-16.27M	-14.59M	-9.85M	-6.08M	-2.37M
EBIT	-192.95M	-200.5M	-204.08M	-192.4M	-164.16M	-157.49M	-128.6M	-125.66M	-126.27M	34.81M	24.56M	65.6M	138.49M	37.96M	42.48M	23.74M	-11.02M	-36.43M	-22.57M	-16.28M	-14.61M	-9.86M	-6.09M	-2.37M
Depreciation & Amortization	416K	416K	416K	416K	416K	416K	418K	357K	276K	179K	80K	45K	29K	28K	26K	22K	19K	17K	16K	16K	17K	13K	9K	5K